Stock Update: CVS Caremark Corporation (NYSE:CVS) – CVS Health Receives URAC Accreditation for Mail Service Pharmacy

[PR Newswire] – WOONSOCKET, R.I., March 29, 2016 /PRNewswire/ — CVS Health (NYSE: CVS) announced today that pharmacy benefits manager CVS Caremark has been awarded Mail Service Pharmacy accreditation from URAC, a Washington, … Read more on this. CVS Health Corporation (CVS) , valued at $112.87B, started trading this morning at $101.74. Looking at the stock, its one day range is $101.01 to $102.85 with a trailing 52-week range being $81.37 to $113.65. CVS (CVS) shares are currently priced at 17.50x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 10.87x earnings multiple for the same period. And for dividend hunters, the company pays shareholders $1.70 per share annually in dividends, yielding 1.68%. In a review of the consensus earnings estimate this quarter, 25 sell-side analysts are looking at $1.16 per share, which would be $0.02 better than the year-ago quarter and a $0.02 sequential decrease. Investors should also note that the full-year EPS estimate of $5.82 is a $0.66 improvement when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $43.02 Billion. If reported, that would be a 18.41% increase over the year-ago quarter. Recently, Atlantic Equities Initiated CVS at Overweight (Feb 3, 2016). Previously, Robert W. Baird Initiated CVS at to Outperform. Given all the information above, we should disclose to readers that the average price target is $111.85, which is 9.94% above than it opened this morning. See more in (NYSE:CVS) Similar Articles: Stock Update: CVS Caremark Corporation (NYSE:CVS) – CVS Health to Expand Access to Opioid Overdose-Reversal Medication at CVS Pharmacy Locations in Eight Additional States Company Update: CVS Caremark Corporation (NYSE:CVS) – CVS Health’s MinuteClinic Marks Decade of Accreditation from The Joint Commission With Latest Evaluation Stock Update: CVS Caremark Corporation (NYSE:CVS) – CVS Health and Target Announce Completed Acquisition of Target’s Pharmacy and Clinic Businesses